文献速递老年精神会诊联络精神医学

老年患者出院后停用抗精神病药的健康结局

Health Outcomes of Discontinuing Antipsychotics After Hospitalization in Older Adults.
PubMed 文献 · JAMA Psychiatry · 2025-01-01

这项基于美国全国医保数据的队列研究纳入无精神障碍且既往未用抗精神病药的65岁以上住院后启用抗精神病药的患者,比较停药与继续用药的临床结局。结果显示停药与再住院、住院谵妄、跌倒相关急诊或住院、尿路感染住院及全因死亡风险降低相关,肺炎和卒中风险无统计学差异。

要点

  • 老年患者出院后停用抗精神病药与再住院和死亡风险降低相关。
  • 停药与跌倒相关急诊或住院、尿路感染住院及住院谵妄风险降低相关。
  • 肺炎和卒中风险在停药与继续用药之间无统计学差异。

核心结论

  • 在无精神障碍的老年住院患者中,出院后停用为处理住院相关谵妄而启用的抗精神病药与全因再住院和死亡风险降低相关。

研究设计与样本

  • 基于美国全国医保索赔数据(2013年7月1日至2018年12月31日)和Optum CDM商业数据库(2004年7月1日至2024年5月31日)的人群队列研究。
  • 纳入65岁及以上、无精神障碍且既往未用抗精神病药、出院30天内填写抗精神病药处方的成人。
  • 采用发生密度抽样按抗精神病药类型、首次处方后时间和首次处方前是否入住ICU匹配停药者(间隔≥45天)与继续用药者。
  • 应用倾向评分匹配调整162个协变量,采用Cox比例风险模型估计风险比,并用固定效应荟萃分析合并两个数据库的估计值。

主要发现

  • 中位随访180天(IQR 87-180天)期间,停药 vs 继续用药与再住院风险降低相关(HR 0.89,95%CI 0.85-0.94)。
  • 停药与住院谵妄风险降低相关(HR 0.87,95%CI 0.79-0.96)。
  • 停药与跌倒相关急诊就诊或住院风险降低相关(HR 0.77,95%CI 0.67-0.90)。
  • 停药与尿路感染住院风险降低相关(HR 0.79,95%CI 0.66-0.94),与全因死亡风险降低相关(HR 0.77,95%CI 0.69-0.86)。
  • 肺炎风险(HR 0.88,95%CI 0.73-1.06)和卒中风险(HR 1.22,95%CI 0.97-1.53)在两组间无统计学差异。

关键数值与推荐

  • 停药定义为抗精神病药处方间隔≥45天。
  • 按痴呆状态、抗精神病药类型和剂量、抗精神病药暴露时长进行的亚组分析结果一致。

临床怎么用

  • 对因住院相关谵妄启用抗精神病药的老年患者,出院后应考虑尽早停用而非长期继续使用。
  • 停药决策需结合患者个体情况,尤其关注痴呆状态、抗精神病药类型和剂量及暴露时长。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Among hospitalized older adults, prolonged use of antipsychotic medications (APMs) following hospital discharge may increase the risk of APM-associated adverse events. There are limited data on whether early discontinuation of APMs is associated with reduced adverse clinical outcomes compared with APM continuation after discharge. OBJECTIVE: To compare clinical outcomes between discontinuation vs continuation of APMs initiated to manage hospitalization-related delirium. DESIGN, SETTING, AND PARTICIPANTS: This population-based cohort study examining nationwide US Medicare claims data from July 1, 2013, through December 31, 2018, and data from a large deidentified US commercial health care database (Optum CDM) from July 1, 2004, through May 31, 2024, included adults aged 65 years and older without psychiatric disorders or previous use of APMs who filled an APM prescription within 30 days of hospital discharge. Using incidence density sampling, APM discontinuers (gap ≥45 days) were matched with continuers based on the type of APM prescribed, the time since their first APM prescription, and whether they had been admitted to intensive care units prior to the first APM prescription. Data analysis was performed from July 12, 2024, to December 25, 2024. EXPOSURE: Discontinuation vs continuation of APMs. MAIN OUTCOMES AND MEASURES: Propensity score matching was applied to adjust for 162 covariates. Study outcomes included rehospitalization, specific rehospitalization reasons, and all-cause mortality. Hazard ratios (HRs) were estimated using the Cox proportional hazards model; estimates from the 2 databases were further pooled using the fixed-effects meta-analysis model. RESULTS: A total of 13 712 propensity score-matched pairs were included, for an overall sample of 27 424 adults (discontinuers: mean [SD] age, 81.86 [7.26] years; 7400 [54.0%] female; continuers: mean [SD] age, 81.86 [7.27] years; 7360 [53.7%] female). During the median (IQR) follow-up of 180 (87-180) days, APM discontinuation vs continuation was associated with significantly lower risks of rehospitalization (HR, 0.89 [95% CI, 0.85-0.94]), inpatient delirium (HR, 0.87 [95% CI, 0.79-0.96]), fall-related emergency department visits or hospitalizations (HR, 0.77 [95% CI, 0.67-0.90]), hospitalization with urinary tract infection (HR, 0.79 [95% CI, 0.66-0.94]), and all-cause mortality (HR, 0.77 [95% CI, 0.69-0.86]). There was no statistical difference in the risks of pneumonia (HR, 0.88 [95% CI, 0.73-1.06]) or stroke (HR, 1.22 [95% CI, 0.97-1.53]) between discontinuers and continuers. Subgroups by dementia status, type and dose of APM prescribed, and duration of APM exposure showed consistent results. CONCLUSIONS AND RELEVANCE: Based on 2 nationwide US cohorts including older adults without psychiatric disorders, APM discontinuation was associated with reduced risks of all-cause rehospitalization and mortality, suggesting the importance of minimizing the duration of APM use after acute hospitalization.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Yang CT, Wilkins JM, DiCesare E, et al. Health Outcomes of Discontinuing Antipsychotics After Hospitalization in Older Adults. JAMA Psychiatry. 2025. PMID: 40366701. doi:10.1001/jamapsychiatry.2025.0702

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。